CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited) - USD ($) $ in Millions	Total	Common stock and additional paid-in capital	Retained earnings/(Accumulated deficit)	Accumulated other comprehensive income/(loss)
Beginning balances at Sep. 28, 2024	$ 56,950	$ 83,276	$ (19,154)	$ (7,172)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued		825
Common stock withheld related to net share settlement of equity awards		(2,097)	(1,187)
Share-based compensation		6,707
Net income	61,110		61,110
Dividends and dividend equivalents declared			(7,613)
Common stock repurchased			(48,708)
Other comprehensive income/(loss)	809			809
Ending balances at Mar. 29, 2025	$ 66,796	88,711	(15,552)	(6,363)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends and dividend equivalents declared per share or RSU (in dollars per share or RSU)	$ 0.50
Beginning balances at Dec. 28, 2024	$ 66,758	84,768	(11,221)	(6,789)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued		825
Common stock withheld related to net share settlement of equity awards		(206)	(85)
Share-based compensation		3,324
Net income	24,780		24,780
Dividends and dividend equivalents declared			(3,794)
Common stock repurchased			(25,232)
Other comprehensive income/(loss)	426			426
Ending balances at Mar. 29, 2025	$ 66,796	88,711	(15,552)	(6,363)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends and dividend equivalents declared per share or RSU (in dollars per share or RSU)	$ 0.25
Beginning balances at Sep. 27, 2025	$ 73,733	93,568	(14,264)	(5,571)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued		878
Common stock withheld related to net share settlement of equity awards		(2,308)	(1,024)
Share-based compensation		7,369
Net income	71,675		71,675
Dividends and dividend equivalents declared			(7,735)
Common stock repurchased	(36,000)		(36,293)
Other comprehensive income/(loss)	196			196
Ending balances at Mar. 28, 2026	$ 106,491	99,507	12,359	(5,375)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends and dividend equivalents declared per share or RSU (in dollars per share or RSU)	$ 0.52
Beginning balances at Dec. 27, 2025	$ 88,190	95,221	(2,177)	(4,854)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued		878
Common stock withheld related to net share settlement of equity awards		(250)	(88)
Share-based compensation		3,658
Net income	29,578		29,578
Dividends and dividend equivalents declared			(3,855)
Common stock repurchased			(11,099)
Other comprehensive income/(loss)	(521)			(521)
Ending balances at Mar. 28, 2026	$ 106,491	$ 99,507	$ 12,359	$ (5,375)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends and dividend equivalents declared per share or RSU (in dollars per share or RSU)	$ 0.26